Contact
searchSearch
HMP Global
Login

April 2016

Research in Review
Human Epidermal Growth Factor Receptor-2 a Strong Indicator of Breast Cancer Prognosis
04/11/2016
Human epidermal growth factor receptor-2 (HER-2) expression may be a key indicator of recurrence risk in patients with breast cancer, though PIK3CA mutations have no prognostic value, according to a recent...
Human epidermal growth factor receptor-2 (HER-2) expression may be a key indicator of recurrence risk in patients with breast cancer, though PIK3CA mutations have no prognostic value, according to a recent...
...
04/11/2016
Journal of Clinical Pathways
Editor's Page
Value in Health Care: In the Eye of the Beholder
04/08/2016
Winston Wong, PharmD
Value is defined differently depending on who is defining it. Still, whether value is being defined by the health care provider, the payer, the patient, or industry, the importance of evidence-based treatment...
Value is defined differently depending on who is defining it. Still, whether value is being defined by the health care provider, the payer, the patient, or industry, the importance of evidence-based treatment...
Value...
04/08/2016
Journal of Clinical Pathways
From the Field
Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center
04/11/2016
Aymen Elfiky, MD, MPH, MSc; Marina Kaymakcalan, PharmD
Abstract: The rising costs associated with cancer care delivery have prompted the health care system to prioritize the principle of value-based care to accentuate the concepts of quality and outcomes. Driven in...
Abstract: The rising costs associated with cancer care delivery have prompted the health care system to prioritize the principle of value-based care to accentuate the concepts of quality and outcomes. Driven in...
...
04/11/2016
Journal of Clinical Pathways
Research Reports
Health Care Use and Costs Among Medicare Patients With Chronic Obstructive Pulmonary Disease Treated With Short-Acting Beta Agonists or Long-Acting Beta Agonists
04/11/2016
Vamsi K. Bollu, PhD, MBA; Flavia Ejzykowicz, PhD; Joel W. Hay, PhD; Krithika Rajagopalan, PhD
Abstract: Chronic obstructive pulmonary disease (COPD) has a high prevalence among older adults and is the third leading cause of mortality in the United States. COPD exacerbations can require hospitalizations,...
Abstract: Chronic obstructive pulmonary disease (COPD) has a high prevalence among older adults and is the third leading cause of mortality in the United States. COPD exacerbations can require hospitalizations,...
...
04/11/2016
Journal of Clinical Pathways
Clinical Pathways GPS
Adding Patient Navigation to the Clinical Pathway for Alzheimer Disease
04/11/2016
Ruth Gay; David Digby; Harold Freeman, MD; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Mary Michael
Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...
Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...
...
04/11/2016
Journal of Clinical Pathways
Pharma Insights
When Medication Price Deflates Perception of Therapeutic Effect
04/11/2016
Larry Blandford, PharmD; Stephen C. Carter, BSc
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
...
04/11/2016
Journal of Clinical Pathways
Interview
Devising Pathways Strategies That Maintain the Principles of Personalized Medicine
04/11/2016
As clinical pathways are utilized by more institutions to provide standardized, evidence-based care for patients with cancer, these tools have demonstrated a clear ability to reduce costs,1 improve hospital...
As clinical pathways are utilized by more institutions to provide standardized, evidence-based care for patients with cancer, these tools have demonstrated a clear ability to reduce costs,1 improve hospital...
As...
04/11/2016
Journal of Clinical Pathways
Conference Coverage
Association of Community Cancer Centers Annual Meeting: CANCERSCAPE 2016
04/11/2016
Since its formation, the Association of Community Cancer Centers (ACCC) has become integral to disseminating oncology standards and new clinical protocols to community cancer programs around the United States. The...
Since its formation, the Association of Community Cancer Centers (ACCC) has become integral to disseminating oncology standards and new clinical protocols to community cancer programs around the United States. The...
Since...
04/11/2016
Journal of Clinical Pathways
Research in Review
Evidence-Based Training to Improve Physician Responses to Adverse Events
04/11/2016
A study published in BMC Medical Education has found that an online game can be an effective and acceptable way to train junior doctors in care relating to adverse events from cancer treatment and increase their...
A study published in BMC Medical Education has found that an online game can be an effective and acceptable way to train junior doctors in care relating to adverse events from cancer treatment and increase their...
A...
04/11/2016
Journal of Clinical Pathways
Research in Review
Number of Positive Nodes Best Prognostic Indicator for Patients With Head and Neck Cancer
04/11/2016
The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...
The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...
The...
04/11/2016
Journal of Clinical Pathways
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

April 2016 Volume 2

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use